Advertisement
UK markets close in 1 hour 6 minutes
  • FTSE 100

    8,359.53
    +45.86 (+0.55%)
     
  • FTSE 250

    20,427.49
    +14.41 (+0.07%)
     
  • AIM

    778.41
    +1.99 (+0.26%)
     
  • GBP/EUR

    1.1615
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2493
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    49,962.45
    -733.45 (-1.45%)
     
  • CMC Crypto 200

    1,325.04
    +30.37 (+2.34%)
     
  • S&P 500

    5,183.45
    -4.25 (-0.08%)
     
  • DOW

    38,910.28
    +26.02 (+0.07%)
     
  • CRUDE OIL

    78.08
    -0.30 (-0.38%)
     
  • GOLD FUTURES

    2,320.50
    -3.70 (-0.16%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,493.63
    +63.58 (+0.34%)
     
  • CAC 40

    8,150.34
    +74.66 (+0.92%)
     

What Kind Of Investors Own Most Of Bioventix PLC (LON:BVXP)?

If you want to know who really controls Bioventix PLC (LON:BVXP), then you'll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Warren Buffett said that he likes "a business with enduring competitive advantages that is run by able and owner-oriented people." So it's nice to see some insider ownership, because it may suggest that management is owner-oriented.

Bioventix is a smaller company with a market capitalization of UK£201m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that institutions are noticeable on the share registry. We can zoom in on the different ownership groups, to learn more about Bioventix.

See our latest analysis for Bioventix

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Bioventix?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

ADVERTISEMENT

As you can see, institutional investors have a fair amount of stake in Bioventix. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Bioventix's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Hedge funds don't have many shares in Bioventix. Castlefield Investment Partners LLP is currently the company's largest shareholder with 20% of shares outstanding. With 10% and 8.0% of the shares outstanding respectively, Liontrust Asset Management PLC and Peter Harrison are the second and third largest shareholders. Peter Harrison, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors.

On further inspection, we found that more than half the company's shares are owned by the top 6 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far I can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

Insider Ownership Of Bioventix

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

We can see that insiders own shares in Bioventix PLC. As individuals, the insiders collectively own UK£17m worth of the UK£201m company. This shows at least some alignment. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public holds a 17% stake in Bioventix. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.